Sun Pharmaceutical Industries Ltd 2019 AR2
The report highlights Sun Pharmaceutical Industries Ltd.'s performance and sustainability initiatives for the fiscal year 2018-19. The company achieved a consolidated revenue of INR 290,659 million, representing a 10% growth, driven by its global specialty business and generic sales. Key sustainability efforts included the construction of 216 individual household toilets under its sanitation program and providing primary healthcare to over 147,000 patients through Mobile Medical Units. On the environmental front, the company generated 2.05 million kWh of clean energy and operated 17 zero liquid discharge facilities.
Company: Sun Pharmaceutical Industries Ltd
Sector: Manufacturing
Country: India
Year: 2019
Type: AR2
Pages: 264
Back to company
Sun Pharmaceutical Industries Ltd
Annual Report
The report highlights Sun Pharmaceutical Industries Ltd.'s performance and sustainability initiatives for the fiscal year 2018-19. The company achieved a consolidated revenue of INR 290,659 million, representing a 10% growth, driven by its global specialty business and generic sales. Key sustainability efforts included the construction of 216 individual household toilets under its sanitation program and providing primary healthcare to over 147,000 patients through Mobile Medical Units. On the environmental front, the company generated 2.05 million kWh of clean energy and operated 17 zero liquid discharge facilities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Apr 1, 2018 - Mar 31, 2019
Fiscal Year
2019
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Water Consumption
Employees